Venture funding rises in 2Q; NGM, Audentes and Lithera grab 3Q deals
This article was originally published in Scrip
Executive Summary
Venture capital funding for US health care companies ramped up in the second quarter of 2013 after several quarters of decline compared to year-ago levels, and recent deals show significant venture dealmaking for biotechnology companies to kick off the third quarter of this year.